Concepedia

Lyuben Tsvetkov

LT

Statistics

Publications

16

Citations

2.4K

H-Index

16

Active since

1997

Affiliations

Yale University(Current)

GlaxoSmithKline (United States)

Institut Gustave Roussy

Target (United States)

Lyuben Tsvetkov is an author at Yale University specializing in life sciences, molecular biology, and cell biology.

Publications per year

1997–2021

16

Publications

16

p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27

Lyuben Tsvetkov, Kun‐Huei Yeh, Soo-Jung Lee et al. · Current Biology · 1999 · 791 citations · Full text

, , +17

The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4

Li Liu, Patrick A. Mayes, Stephen D. Eastman et al. · Clinical Cancer Research · 2015 · 447 citations

, , +17

PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2

Ramanaiah Mamillapalli, Nadia J. Gavrilova, Valia T. Mihaylova et al. · Current Biology · 2001 · 224 citations · Full text

, , +16

Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments

Jong W. Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra et al. · PLoS ONE · 2018 · 205 citations · Full text

, , +17

Chk2 Activation and Phosphorylation-Dependent Oligomerization

Xingzhi Xu, Lyuben Tsvetkov, David F. Stern · Molecular and Cellular Biology · 2002 · 182 citations · Full text

, , +15

1–5 of 16